Neogen Company Top Insiders
| NEOG Stock | USD 14.14 0.03 0.21% |
Neogen's insiders are aggressively buying. The analysis of insiders' sentiment of trading Neogen stock suggests that almost all insiders are extremely bullish at this time. Neogen employs about 2.9 K people. The company is managed by 10 executives with a total tenure of roughly 26 years, averaging almost 2.0 years of service per executive, having 291.7 employees per reported executive.
| John Adent CEO CEO President |
| Robert Donofrio President Vice President - Food Safety Research and Development |
Neogen's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2024-10-11 | John Edward Adent | Acquired 14500 @ 13.8 | View | ||
| 2024-08-06 | James P Tobin | Acquired 3000 @ 16.86 | View | ||
| 2024-04-17 | Douglas Edward Jones | Acquired 10000 @ 12.36 | View | ||
| 2024-04-11 | James C Borel | Acquired 7500 @ 13.06 | View | ||
| 2024-04-10 | John Edward Adent | Acquired 23000 @ 12.36 | View |
Monitoring Neogen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Neogen |
Neogen's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Neogen's future performance. Based on our forecasts, it is anticipated that Neogen will maintain a workforce of roughly 2920 employees by December 2024.Neogen's latest congressional trading
Congressional trading in companies like Neogen, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Neogen by those in governmental positions are based on the same information available to the general public.
| 2019-07-01 | Representative Greg Gianforte | Acquired $100K to $250K | Verify |
Neogen Management Team Effectiveness
The Neogen's current Return On Tangible Assets is estimated to increase to -0.0099. The current Return On Capital Employed is estimated to decrease to 0.01. At this time, Neogen's Other Current Assets are most likely to increase significantly in the upcoming years. The Neogen's current Total Current Assets is estimated to increase to about 618.7 M, while Other Assets are projected to decrease to 0.95. Neogen's management efficiency ratios could be used to measure how well Neogen manages its routine affairs as well as how well it operates its assets and liabilities.The Neogen's current Common Stock Shares Outstanding is estimated to increase to about 227.3 M, while Net Loss is forecasted to increase to (25 M).
Neogen Workforce Comparison
Neogen is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 158,561. Neogen claims roughly 2,917 in number of employees contributing just under 2% to equities under Health Care industry.
Neogen Profit Margins
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.57 | 0.5019 |
|
|
Neogen Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Neogen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-12-01 | 1.1667 | 49 | 42 | 382,805 | 212,670 |
| 2024-09-01 | 3.25 | 13 | 4 | 1,597,910 | 23,842 |
| 2024-06-01 | 2.2 | 11 | 5 | 140,086 | 4,427 |
| 2023-12-01 | 10.6667 | 32 | 3 | 2,048,000 | 4,859 |
| 2023-09-01 | 0.5 | 1 | 2 | 1,500 | 3,000 |
| 2023-03-01 | 1.0 | 2 | 2 | 4,000 | 2,250 |
| 2022-12-01 | 14.0 | 28 | 2 | 1,229,540 | 159,272 |
| 2022-03-01 | 1.0 | 2 | 2 | 4,400 | 6,000 |
| 2021-12-01 | 12.5 | 25 | 2 | 306,380 | 1,272 |
| 2021-09-01 | 1.2 | 6 | 5 | 49,626 | 56,360 |
| 2021-06-01 | 0.4 | 4 | 10 | 19,106 | 39,555 |
| 2021-03-01 | 0.6486 | 24 | 37 | 184,934 | 366,554 |
| 2020-12-01 | 1.5882 | 27 | 17 | 205,178 | 117,939 |
| 2020-09-01 | 0.5 | 2 | 4 | 31,014 | 62,028 |
| 2020-03-01 | 0.5135 | 19 | 37 | 96,169 | 396,687 |
| 2019-12-01 | 0.6364 | 21 | 33 | 351,902 | 498,588 |
| 2019-09-01 | 0.2 | 5 | 25 | 69,002 | 294,429 |
| 2019-06-01 | 0.25 | 7 | 28 | 35,169 | 188,554 |
| 2019-03-01 | 0.1538 | 2 | 13 | 30,134 | 152,961 |
| 2018-12-01 | 1.3846 | 18 | 13 | 236,381 | 120,773 |
| 2018-09-01 | 0.4 | 14 | 35 | 94,870 | 375,520 |
| 2018-06-01 | 0.375 | 6 | 16 | 218,429 | 463,420 |
| 2018-03-01 | 0.2917 | 7 | 24 | 41,200 | 137,204 |
| 2017-12-01 | 1.1364 | 25 | 22 | 273,083 | 205,241 |
| 2017-09-01 | 0.3704 | 10 | 27 | 60,981 | 281,238 |
| 2017-06-01 | 0.3846 | 5 | 13 | 61,928 | 182,864 |
| 2017-03-01 | 0.5556 | 5 | 9 | 38,952 | 79,904 |
| 2016-12-01 | 0.7 | 14 | 20 | 114,450 | 200,150 |
| 2016-09-01 | 0.6667 | 18 | 27 | 309,929 | 220,706 |
| 2016-06-01 | 0.75 | 6 | 8 | 27,250 | 58,500 |
| 2016-03-01 | 0.3636 | 4 | 11 | 45,099 | 114,245 |
| 2015-12-01 | 1.3077 | 17 | 13 | 373,000 | 176,500 |
| 2015-09-01 | 0.5 | 16 | 32 | 92,588 | 204,444 |
| 2015-06-01 | 0.5 | 3 | 6 | 31,625 | 67,235 |
| 2015-03-01 | 0.4286 | 3 | 7 | 45,872 | 89,194 |
| 2014-12-01 | 3.0 | 15 | 5 | 297,250 | 36,250 |
| 2014-09-01 | 0.6667 | 10 | 15 | 55,876 | 92,124 |
| 2014-06-01 | 0.4444 | 4 | 9 | 31,688 | 63,376 |
| 2014-03-01 | 0.5 | 4 | 8 | 53,284 | 106,568 |
| 2013-12-01 | 0.6389 | 23 | 36 | 135,925 | 223,100 |
| 2013-09-01 | 0.4722 | 17 | 36 | 238,090 | 379,169 |
| 2013-06-01 | 0.5909 | 13 | 22 | 105,105 | 208,096 |
| 2013-03-01 | 0.4286 | 3 | 7 | 6,255 | 50,163 |
| 2012-12-01 | 1.0 | 19 | 19 | 229,625 | 252,841 |
| 2012-09-01 | 0.5263 | 10 | 19 | 95,911 | 187,247 |
| 2012-06-01 | 0.5 | 4 | 8 | 19,719 | 39,238 |
| 2011-12-01 | 1.1875 | 19 | 16 | 76,425 | 98,664 |
| 2011-09-01 | 3.1667 | 19 | 6 | 153,706 | 44,014 |
| 2011-06-01 | 0.4286 | 6 | 14 | 50,259 | 105,208 |
| 2011-03-01 | 0.3636 | 8 | 22 | 36,508 | 121,466 |
| 2010-12-01 | 0.6378 | 81 | 127 | 236,880 | 366,153 |
| 2010-09-01 | 0.7297 | 27 | 37 | 174,538 | 89,124 |
| 2010-06-01 | 0.5 | 5 | 10 | 25,221 | 50,442 |
| 2009-12-01 | 0.7451 | 38 | 51 | 196,338 | 327,272 |
| 2009-09-01 | 0.75 | 42 | 56 | 294,719 | 121,132 |
| 2009-06-01 | 2.0 | 8 | 4 | 4,208 | 2,408 |
| 2009-03-01 | 0.4375 | 7 | 16 | 23,852 | 59,000 |
| 2008-12-01 | 0.7586 | 22 | 29 | 56,737 | 95,739 |
| 2008-09-01 | 1.1538 | 15 | 13 | 173,397 | 51,604 |
| 2008-06-01 | 0.5429 | 19 | 35 | 86,067 | 179,266 |
| 2008-03-01 | 0.8667 | 13 | 15 | 39,125 | 58,168 |
| 2007-12-01 | 0.7188 | 23 | 32 | 95,671 | 136,835 |
| 2007-09-01 | 1.05 | 21 | 20 | 221,540 | 158,249 |
| 2007-06-01 | 0.5641 | 22 | 39 | 71,964 | 129,951 |
| 2007-03-01 | 0.3929 | 11 | 28 | 20,164 | 57,728 |
| 2006-12-01 | 1.8571 | 13 | 7 | 144,750 | 8,818 |
| 2006-09-01 | 0.7333 | 11 | 15 | 60,334 | 110,933 |
| 2006-06-01 | 0.2857 | 6 | 21 | 175,107 | 504,972 |
| 2006-03-01 | 0.2609 | 6 | 23 | 12,400 | 40,050 |
| 2005-12-01 | 0.7826 | 18 | 23 | 186,375 | 122,475 |
| 2005-06-01 | 1.0 | 1 | 1 | 1,300 | 1,300 |
| 2004-09-01 | 0.625 | 5 | 8 | 27,416 | 34,799 |
| 2004-03-01 | 0.5 | 2 | 4 | 18,069 | 27,469 |
| 2003-12-01 | 1.1 | 22 | 20 | 218,617 | 88,357 |
Neogen Notable Stakeholders
A Neogen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Neogen often face trade-offs trying to please all of them. Neogen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Neogen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| John Adent | CEO President | Profile | |
| Robert Donofrio | Vice President - Food Safety Research and Development | Profile | |
| Steven Quinlan | CFO, Principal Accounting Officer, VP and Secretary | Profile | |
| John Moylan | Corporate VP | Profile | |
| Bill Waelke | Head Relations | Profile | |
| Julie Mann | VP Officer | Profile | |
| Amy Rocklin | Chief Secretary | Profile | |
| David Naemura | Chief Officer | Profile | |
| Sarah Demey | Administrative Manager | Profile | |
| Douglas Jones | COO VP | Profile |
About Neogen Management Performance
The success or failure of an entity such as Neogen often depends on how effective the management is. Neogen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.01 | 0.01 |
Neogen Workforce Analysis
Traditionally, organizations such as Neogen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Neogen within its industry.Neogen Manpower Efficiency
Return on Neogen Manpower
| Revenue Per Employee | 316.8K | |
| Revenue Per Executive | 92.4M | |
| Net Loss Per Employee | 3.2K | |
| Net Loss Per Executive | 942.1K | |
| Working Capital Per Employee | 149.1K | |
| Working Capital Per Executive | 43.5M |
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |